27.3 C
New York

Understanding Metastatic Epithelioid Mesothelioma | Symptoms, Treatment, and Prognosis

Published:

Introduction

Metastatic epithelioid mesothelioma is a deadly and complex disease that affects the lining of the chest cavity, abdomen, or heart. It is a rare form of cancer caused by exposure to asbestos fibers, with a median survival time of less than a year. Despite advances in treatment approaches, the overall prognosis for patients with metastatic epithelioid mesothelioma remains poor. In this article, we will delve into the complexities of this disease, exploring its causes, symptoms, diagnosis, treatment options, and ongoing research efforts.

What is Metastatic Epithelioid Mesothelioma?

Mesothelioma is a type of cancer that develops in the mesothelium, a thin layer of tissue that lines the body’s internal organs. It is most commonly caused by exposure to asbestos fibers, which can become trapped in the mesothelium and cause chronic inflammation and cellular damage. There are three main types of mesothelioma: pleural, peritoneal, and pericardial. Out of these, epithelioid mesothelioma is the most common, accounting for approximately 60% of all cases.

Epithelioid mesothelioma is characterized by the presence of cells resembling epithelial cells, which normally line the body’s surfaces. These cancerous cells tend to form solid tumors that can grow rapidly, invading surrounding tissues and spreading to distant organs. Due to the aggressive nature of this type of mesothelioma, it often becomes metastatic, meaning it spreads to other parts of the body.

Symptoms of Metastatic Epithelioid Mesothelioma

The symptoms of metastatic epithelioid mesothelioma can vary depending on the location of the cancerous cells. However, there are some common symptoms that may occur in all types of mesothelioma. These include:

  • Chest pain
  • Shortness of breath
  • Fatigue
  • Weight loss
  • Abdominal pain
  • Nausea and vomiting
  • Swelling in the abdomen
  • Heart palpitations

In addition to these general symptoms, patients with metastatic epithelioid mesothelioma may also experience symptoms specific to the affected area. For example, those with pleural mesothelioma may experience difficulty breathing and a persistent cough, while those with peritoneal mesothelioma may have bowel obstructions, abdominal swelling, and digestive issues.

Diagnosis and Staging

Due to its rarity and the non-specific nature of its symptoms, mesothelioma can be challenging to diagnose. The first step in diagnosing metastatic epithelioid mesothelioma is typically a physical exam and review of the patient’s medical history. This may be followed by imaging tests such as X-rays, CT scans, or MRI scans to look for any abnormalities in the affected areas.

A definitive diagnosis of mesothelioma requires a biopsy, where a sample of tissue is removed from the affected area for examination under a microscope. This allows doctors to determine if the tumor is cancerous and what type of mesothelioma it is. In some cases, a thoracoscopy or laparoscopy may also be performed to obtain a tissue sample.

Once a diagnosis of mesothelioma is confirmed, the next step is determining the stage of the cancer. This is done through various imaging tests and procedures, such as PET scans, bone scans, and blood tests. The stage of mesothelioma refers to how far the cancer has spread and helps doctors develop an appropriate treatment plan.

Treatment Options

The treatment options for metastatic epithelioid mesothelioma depend on several factors, including the stage of the cancer, the location of the tumors, and the overall health of the patient. The main treatment approaches for mesothelioma are surgery, chemotherapy, radiation therapy, and immunotherapy. These may be used alone or in combination to achieve the best possible outcome.

Surgery is often the first-line treatment for mesothelioma, as it offers the best chance of removing as much of the cancerous tissue as possible. The type of surgery performed will depend on the location of the tumors. For pleural mesothelioma, a common procedure is pleurectomy/decortication, where the lining of the lung and chest cavity is removed. In some cases, an extrapleural pneumonectomy may be necessary, which involves removing the entire lung along with the lining of the chest and heart.

For peritoneal mesothelioma, the main surgical option is cytoreductive surgery, where the tumors in the abdomen are removed. This may be followed by heated intraperitoneal chemotherapy (HIPEC), where heated chemotherapy drugs are circulated throughout the abdominal cavity.

Chemotherapy is another commonly used treatment for metastatic epithelioid mesothelioma. It involves using powerful drugs to kill cancer cells and shrink tumors. Chemotherapy may be administered orally, intravenously, or directly into the affected area through a catheter. While it can be effective in slowing tumor growth and improving symptoms, it can also have significant side effects such as nausea, hair loss, and fatigue.

Radiation therapy uses high-energy X-rays or other types of radiation to kill cancer cells and shrink tumors. It may be used as a primary treatment for patients who are not eligible for surgery, or in combination with surgery and/or chemotherapy. Like chemotherapy, radiation therapy can cause side effects such as fatigue, skin irritation, and difficulty swallowing.

Immunotherapy is a newer treatment option for mesothelioma that involves boosting the body’s immune system to fight against cancer cells. It works by targeting specific proteins on cancer cells and helps the immune system recognize and destroy them. While it has shown promise in treating some forms of mesothelioma, it is still in the early stages of research.

Prognosis and Survival Rates

The prognosis for patients with metastatic epithelioid mesothelioma remains poor, with a median survival time of less than a year. This is due to several factors, including late diagnosis, aggressive nature of the cancer, and limited treatment options. However, with advancements in treatments and better understanding of the disease, there have been some improvements in survival rates in recent years.

According to the American Cancer Society, the overall 5-year survival rate for mesothelioma is around 10%, meaning that only 1 in 10 patients will live for at least five years after being diagnosed. The survival rate is higher in patients who are diagnosed in the earlier stages of the disease and receive aggressive treatment. However, even these patients may experience a recurrence of the cancer, which can be difficult to treat.

Research and Clinical Trials

As mesothelioma is a rare and complex disease, there is ongoing research to find more effective treatment options and improve the overall prognosis for patients. One area of interest is immunotherapy, where researchers are exploring ways to use a patient’s own immune system to fight against mesothelioma cells.

Clinical trials are also being conducted to test new drugs and treatment methods for mesothelioma. These trials are essential for finding more effective treatments and improving survival rates. Patients who are interested in participating in clinical trials should discuss this option with their doctor.

Conclusion

Metastatic epithelioid mesothelioma is a deadly and complex disease that requires swift and aggressive treatment. While there have been advancements in treatment options, the overall prognosis for patients remains poor. Early detection and prompt treatment can improve survival rates, but more research and clinical trials are needed to find better treatment options and ultimately, a cure for this devastating disease.

Related articles

Recent articles

spot_img